1-4 of 4
nose diseases
Close
Sort by
Journal Articles

Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study

Hua Wang, MD, Wei Luo, Yue Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 2928.
https://doi.org/10.1182/blood-2018-99-113265
Published: 2018
Journal Articles

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Hua Wang, PhD, Xiao-qin Chen, Wei-da Wang, Zhong-jun Xia, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2787.
https://doi.org/10.1182/blood.V130.Suppl_1.2787.2787
Published: 2017
Journal Articles

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

Clinical Trials & Observations
Wing-yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai, Shigeo Nakamura, Won-Seog Kim, Ivy Sng, Julie Vose, James O. Armitage, Raymond Liang, for the International Peripheral T-Cell Lymphoma Project
Journal: Blood
Blood (2009) 113 (17): 3931–3937.
https://doi.org/10.1182/blood-2008-10-185256
Published: 2009
Includes: Supplemental data
Journal Articles

Clinical and Pathological Differences between Nasal and Nasal-Type NK/T Cell Lymphomas: A Summary of 136 Cases from the International T Cell Lymphoma (ITCL) Project.

Wing Au, MD, Tanin Intragumtornchai, MD, Shigeo Nakamura, MD, James Olen Armitage, MD, Raymond Liang, MD
Journal: Blood
Blood (2006) 108 (11): 292.
https://doi.org/10.1182/blood.V108.11.292.292
Published: 2006